AI in Action: DeepMerkel May Help Predict the Course and Severity of MCC
Artificial intelligence (AI) can determine the course and severity of Merkel cell carcinomas (MCC), enhancing clinical decision making, a new study suggests. For the study, researchers combined machine learning with clinical expertise to develop a web-based system called “DeepMerkel” which offers the power to predict MCC treatment-specific outcomes based on personal and tumour specific features. […]